BioNova Pharmaceuticals (Shanghai) Ltd.
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2018-12-25
- Employees
- 11
- Market Cap
- -
- Website
- http://www.bionovapharma.com
The Effect of Food on the Pharmacokinetics of BN104 Tablets
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Target Recruit Count
- 16
- Registration Number
- NCT06724549
- Locations
- 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
A Study of BN104 in the Treatment of Acute Leukemia
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Target Recruit Count
- 90
- Registration Number
- NCT06052813
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, China
Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- Conditions
- B-cell LymphomaDiffuse Large B Cell LymphomaMantle Cell LymphomaNon Hodgkin LymphomaFollicular Lymphoma
- Interventions
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Target Recruit Count
- 9
- Registration Number
- NCT05611853
- Locations
- 🇨🇳
The First Affiliated School of Guangxi Medical University, Nanning, China
🇨🇳The first affiliated hospital, Zhejiang Unviersity school of medicine, Hangzhou, China
🇨🇳Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, China
A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Registration Number
- NCT05365100
- Locations
- 🇨🇳
ZhuJiang Hospital of Southern Medical University, Guangzhou, China
🇨🇳The First Affiliated School of Guangxi Medical University, Nanning, China
🇨🇳Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, China
Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Target Recruit Count
- 30
- Registration Number
- NCT04930562
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
🇨🇳Xinqiao Hospital, Army Medical University, Chongqing, China
🇨🇳Guangzhou First People's Hospital, Guangzhou, China